Human-murine chimeras of ICAM-1 identify amino acid residues critical for rhinovirus and antibody binding - PubMed (original) (raw)

Comparative Study

Human-murine chimeras of ICAM-1 identify amino acid residues critical for rhinovirus and antibody binding

R B Register et al. J Virol. 1991 Dec.

Abstract

Human ICAM-1 is the cellular receptor for the major group of human rhinoviruses (HRVs). Previous studies have suggested that the N-terminal domain of ICAM-1 is critical for binding of the major group rhinoviruses. To further define the residues within domain 1 that are involved in virus binding, we constructed an extensive series of ICAM-1 cDNAs containing single and multiple amino acid residue substitutions. In each case, substitutions involved replacement of the human amino acids with those found in murine ICAM-1 to minimize conformational effects. To facilitate the mutagenesis process, a synthetic gene encompassing the first two domains of ICAM-1 was constructed which incorporated 27 additional restriction sites to allow mutagenesis by oligonucleotide replacement. Each of the new constructs was placed into a Rous sarcoma virus vector and expressed in primary chicken embryo fibroblast cells. Binding assays were performed with six major group HRVs, including one high-affinity binding mutant of HRV-14, and two monoclonal antibodies. Results indicated that different serotypes displayed a range of sensitivities to various amino acid substitutions. Amino acid residues of ICAM-1 showing the greatest effect on virus and antibody binding included Pro-28, Lys-29, Leu-30, Leu-37, Lys-40, Ser-67, and Pro-70.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Proteins. 1990;7(3):227-33 - PubMed
    1. Bioessays. 1986 Dec;5(6):270-4 - PubMed
    1. J Virol. 1990 Jun;64(6):2582-7 - PubMed
    1. J Virol. 1984 Aug;51(2):340-5 - PubMed
    1. Virology. 1991 Feb;180(2):754-62 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources